T2-weighted imaging-based radiomic-clinical machine learning model for predicting the differentiation of colorectal adenocarcinoma

doi:10.4251/wjgo.v16.i3.819

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2452)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1266

Figures (1-10)

348

Tables (1-3)

228

Sum=1897

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

399

Sum=488

Mar 15, 2024 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Mar 15, 2024; 16(3): 819-832
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.819

Full Size Figure Download Figure

Figure 10 Decision curve analysis of the prediction model. A: The training cohort; B: The validation cohort. The three models (clinical, radiomic, and radiomic-clinical model) showed good clinical applicability in a certain range. DCA: Decision curve analysis.

Citation: Zheng HD, Huang QY, Huang QM, Ke XT, Ye K, Lin S, Xu JH. T2-weighted imaging-based radiomic-clinical machine learning model for predicting the differentiation of colorectal adenocarcinoma. World J Gastrointest Oncol 2024; 16(3): 819-832
URL: https://www.wjgnet.com/1948-5204/full/v16/i3/819.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.819